These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32494165)

  • 21. Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1.
    Liu K; Du S; Gao P; Zheng J
    J Cancer; 2019; 10(18):4196-4207. PubMed ID: 31413738
    [No Abstract]   [Full Text] [Related]  

  • 22. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
    Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
    Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-23a-3p/SIX1 regulates glucose uptake and proliferation through GLUT3 in head and neck squamous cell carcinomas.
    Wang H; Xue W; Ouyang W; Jiang X; Jiang X
    J Cancer; 2020; 11(9):2529-2539. PubMed ID: 32201523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis.
    Zhang J; Cheng Q; Zhou Y; Wang Y; Chen X
    Oral Oncol; 2013 Nov; 49(11):1043-50. PubMed ID: 24035721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
    Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
    Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies.
    St John MA; Wang G; Luo J; Dohadwala M; Hu D; Lin Y; Dennis M; Lee JM; Elashoff D; Lawhon T; Zaknoen SL; Burrows FJ; Dubinett SM
    Br J Cancer; 2012 Aug; 107(4):707-12. PubMed ID: 22828609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rab11a Is Overexpressed in Gastric Cancer and Regulates FAK/AKT Signaling.
    Du J; Fu L; Hao J; Lin X; Dong Q
    J Oncol; 2020; 2020():3494396. PubMed ID: 33178272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
    Liao J; Yang Z; Carter-Cooper B; Chang ET; Choi EY; Kallakury B; Liu X; Lapidus RG; Cullen KJ; Dan H
    Clin Exp Metastasis; 2020 Apr; 37(2):283-292. PubMed ID: 32020377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma.
    Liu H; Chen X; Yang X; Li M; Zhang W; Zhang G; Zhan X; Cao L; Li W; Huang Z; Gao R
    Oncol Lett; 2020 Dec; 20(6):394. PubMed ID: 33193854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
    Fujii R; Imanishi Y; Shibata K; Sakai N; Sakamoto K; Shigetomi S; Habu N; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Kameyama K; Fujii M; Ogawa K
    J Exp Clin Cancer Res; 2014 May; 33(1):40. PubMed ID: 24887090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.
    Wu X; Li J; Yan T; Ke X; Li X; Zhu Y; Yang J; Li Z
    Cancer Cell Int; 2021 Jul; 21(1):393. PubMed ID: 34303375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rab14 Overexpression Promotes Proliferation and Invasion Through YAP Signaling in Non-Small Cell Lung Cancers.
    Zhang J; Zhao X; Luan Z; Wang A
    Onco Targets Ther; 2020; 13():9269-9280. PubMed ID: 32982313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
    BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LATS1 inhibits metastasis and epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
    Wu J; Zhao Z; Zhang H; Kong F; Jiang H; Huang K; Zheng H
    Int J Clin Exp Pathol; 2018; 11(4):2053-2063. PubMed ID: 31938312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RASSF6 Is Downregulated In Human Bladder Cancers And Regulates Doxorubicin Sensitivity And Mitochondrial Membrane Potential Via The Hippo Signaling Pathway.
    Tan S; Bian X; Wu B; Chen X
    Onco Targets Ther; 2019; 12():9189-9200. PubMed ID: 31807003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
    Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
    Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.